Navigation Links
Velos, Inc. Appoints William Broucek Senior Director, Professional Services
Date:3/12/2009

FREMONT, Calif., March 12 /PRNewswire/ -- Velos, Inc., the recognized leader and trusted resource for clinical trials management information systems, has appointed William Broucek to the position of Senior Director, Professional Services. Velos developed this role to address needs coming out of its significant growth during the past two years. Broucek was hired to ensure that superior customer service is sustained while its market leadership continues to expand.

"Excellence in meeting the singular needs of each customer has to keep pace with the excellence and reputation of our clinical research software product suite," said John S. McIlwain, President and CEO of Velos. "Broucek is safeguarding that objective as he oversees and directs our front line project managers, supporting them with strong technical expertise and resources."

Broucek is a healthcare software professional with proven success, leading professional services and operations groups to complete implementation projects of all sizes on time and within budget. Previously, Broucek held senior positions in professional services and implementation management with Bay Area companies that include Agistix, iKnowMed, a Division of US Oncology, Oacis Healthcare Systems, and Fritz Companies, Inc.

"We are very pleased to have Bill Broucek as a member of our management team," continued McIlwain. "His excellent interpersonal, analytical and leadership skills have garnered a warm respect among our project managers. This, combined with Bill's solid systems knowledge, adds depth and breadth to the services we can offer to our valued customers."

About Velos

Velos, Inc. is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S. Its customers include 21 of the top 25 academic medical centers and research institutions. Among the 100 largest recipients of NIH clinical research funding, Velos customers receive over 50% of NIH extramural grants. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to collaborate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Founded in 1996, Velos is privately held with headquarters in Fremont, California. For more information, visit www.velos.com.

This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.


'/>"/>
SOURCE Velos, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RoundTable Appoints Senior Healthcare Executives
2. BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer
3. Chiltern Appoints Jane Turner as Late Phase Director for Europe
4. American Academy of Orthopaedic Surgeons Appoints Peter Mandell, MD, Chair of the Council on Advocacy
5. Endo Pharmaceuticals Appoints William Montague to Board of Directors
6. Streamline Health Appoints Jay D. Miller to Board of Directors
7. Nyer Medical Appoints Sandra Zimmerman as Chief Financial Officer
8. Cynosure Appoints William T. Kelley as Senior Vice President of International Sales
9. American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer
10. Laser Therapy Disappoints in Stroke Trial
11. Mardil Inc. Appoints Medical Device Veteran Daniel A. Pelak to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... ... Butler Mobility invited Ken Matthews to visit its manufacturing facility and showroom ... impressed with the safety and reliability of the Stannah Stairlift as well as with ... endorsement by Ken Matthews can be heard on News Radio WHP 580 weekdays from ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ET, http://www.fdanews.com/deviceapproval ... asking before selecting an FDA approval pathway? , How should they evaluate ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program will ... Trinity Health and the U.S. Soccer Foundation announced today that they have awarded ... Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals of ...
(Date:2/17/2017)... ... ... Like most hospitals across the nation, Onslow Memorial Hospital is looking for ... Reduction Program (HRRP), the return of a patient to the hospital within 30 days ... many providers are struggling to leverage limited resources and technology, Onslow Memorial Hospital has ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... 17, 2017   Parker Waichman LLP, ... rights of victims injured by medical devices, comments ... call for better reporting. Congress required hospitals to ... concerns involving power morcellators and duodenoscopes prompted the ... how hospitals report injuries and deaths related to ...
(Date:2/17/2017)... CINCINNATI , Feb. 17, 2017  Ethicon, ... Torax Medical, Inc., a privately held medical device ... Reflux Management System, a novel minimally invasive ... acquisition of Torax Medical will enable Ethicon to ... the anatomy-altering laparoscopic Nissen fundoplication surgical procedure. 1 ...
(Date:2/17/2017)... (NYSE, TASE: PRGO) today announced it has received final approval ... and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per ... oral solution (syrup), 5 mg/1.5 mg per 5 mL is ... children 6 years of age and older. Annual sales for ...   ...
Breaking Medicine Technology: